My mistake on that one, the layout in which their report was done the last few times made me think it's was in the green, you are correct.
What we need from QBL moving forward is prospective gains from their/our investment, what do they think Medcan is going to bring them to revenue wise once all is said and done, i said this on another thread for QBL that plenty of other companies in the related field have been able to give indication on what crops will lead too $$$ wise.
- Forums
- ASX - By Stock
- CGB
- Ann: Q&A on the merger of QBL MCL and Medcan
Ann: Q&A on the merger of QBL MCL and Medcan, page-324
-
- There are more pages in this discussion • 225 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online